TrialArthritis and rheumatism2008

A pilot study to evaluate the safety and efficacy of the long-acting interleukin-1 inhibitor rilonacept (interleukin-1 Trap) in patients with familial cold autoinflammatory syndrome.

Raphaela Goldbach-Mansky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.